CME Mission Statement
ASCRS’ continuing medical education mission is to improve the competence of ophthalmologists/anterior segment surgeons by offering an avenue for the presentation and discussion of innovative techniques and technologies and fostering an open environment where current practices are presented and questions and improvements in patient care are continually sought.
Accreditation Statement
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.
Designation Statement
The American Society of Cataract and Refractive Surgery designates the ASCRS Glaucoma Day for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
All CME activities approved for AMA PRA Category 1 Credit™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.
Physicians can claim CME credit up to the maximum listed above for attending the Physicians Program (ASCRS), including scientific films and posters on-demand, scientific papers, courses, symposia and general sessions). Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits. Note: All attendees must have their badges to be eligible to claim credits and evaluate the program.
Target Audience
Practicing ophthalmologists who care for patients with glaucoma‐related conditions.
Educational Objectives
- Effectively evaluate current and new diagnostic testing modalities to assist in the early diagnosis of the glaucoma patient and glaucoma suspect as well as disease progression
- Make treatment decisions using evidence-based recommendations regarding the use of pharmacologic and laser therapies for the treatment of glaucoma
- Evaluate best phacoemulsification treatment options and considerations for patients with complex, pre-existing, and advanced glaucoma
- Discuss recent and emerging microinvasive glaucoma surgical (MIGS) options
- Integrate pearls to improve glaucoma surgical outcomes
- Implement strategies to manage glaucoma surgical outcomes
- Give examples of how to include AI and/or Virtual Reality in glaucoma treatments